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Hypothermia is increasingly used as a therapeutic measure to treat brain injury.
However, the cellular mechanisms underpinning its actions are complex and are
not yet fully elucidated. Astrocytes are the most abundant cell type in the brain
and are likely to play a critical role. In this study, transcriptional changes and
the protein expression profile of human primary cortical astrocytes cultured under
hypoxic conditions for 6 h were investigated. Cells were treated either with or without
a mild hypothermic intervention 2 h post-insult to mimic the treatment of patients
following traumatic brain injury (TBI) and/or stroke. Using human gene expression
microarrays, 411 differentially expressed genes were identified following hypothermic
treatment of astrocytes following a 2 h hypoxic insult. KEGG pathway analysis indicated
that these genes were mainly enriched in the Wnt and p53 signaling pathways,
which were inhibited following hypothermic intervention. The expression levels of
168 genes involved in Wnt signaling were validated by quantitative real-time-PCR
(qPCR). Among these genes, 10 were up-regulated and 32 were down-regulated
with the remainder unchanged. Two of the differentially expressed genes (DEGs),
p38 and JNK, were selected for validation at the protein level using cell based
ELISA. Hypothermic intervention significantly down-regulated total protein levels for the
gene products of p38 and JNK. Moreover, hypothermia significantly up-regulated the
phosphorylated (activated) forms of JNK protein, while downregulating phosphorylation
of p38 protein. Within the p53 signaling pathway, 35 human apoptosis-related
proteins closely associated with Wnt signaling were investigated using a Proteome
Profiling Array. Hypothermic intervention significantly down-regulated 18 proteins, while
upregulating one protein, survivin. Hypothermia is a complex intervention; this study
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provides the first detailed longitudinal investigation at the transcript and protein
expression levels of the molecular effects of therapeutic hypothermic intervention on
hypoxic human primary cortical astrocytes. The identified genes and proteins are targets
for detailed functional studies, which may help to develop new treatments for brain injury
based on an in-depth mechanistic understanding of the astrocytic response to hypoxia
and/or hypothermia.
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INTRODUCTION
Therapeutic hypothermia involves the controlled reduction of
core temperature to minimize the secondary damage that occurs
after a primary injury (Moore et al., 2011). Clinicians have
been increasingly using therapeutic hypothermia to prevent
or improve a wide range of neurological morbidities (Yenari
and Han, 2012). The neuroprotective effect of therapeutic
hypothermia has been confirmed in a number of clinical trials
investigating the outcomes of patients suffering from neonatal
hypoxia-ischemia (Gluckman et al., 2005; Shankaran et al., 2005)
and cardiac arrest (Bernard et al., 2002). Hypothermia was
reported to be neuroprotective in stroke patients (Yenari and
Hemmen, 2010) but in human trials in patients suffering from a
traumatic brain injury (TBI), a therapeutic role for hypothermia
is controversial; different clinical trials have reported both
positive and negative outcomes on patient recovery (Andrews
et al., 2015; Lazaridis and Robertson, 2016).
The degree of cooling, duration of treatment and rate of
rewarming of the brain vary between studies and trials. This
may be one reason for the variable efficacy and side effects
described (Carney et al., 2017). Current literature suggests
that the optimal temperature for neuroprotection is 32–34◦C
(Yenari and Hemmen, 2010; Kim and Yenari, 2015). However,
the optimal duration for hypothermia has not been defined
therapeutically (Kim and Yenari, 2015). The precise mechanism
of action underlying hypothermic intervention is still not
understood owing to the complex mechanisms involved, which
have been reported to include alterations in gene and protein
expression, cellular signaling pathways and changes in cellular
microstructure (Yenari and Han, 2012). It is also generally
accepted that the early stages of brain edema formation (within
the first 24–72 h) tend to be cytotoxic edema (with a swollen
but intact astrocytic cell morphology), followed by a later
vasogenic edema, characterized by disruption to the cellular
structures (Unterberg et al., 2004). This may also underlie
different outcomes following hypothermic intervention.
Astrocytes are the most abundant cell type of the brain and
generally have a greater capacity than neurons to survive stresses
(Jäkel and Dimou, 2017). Astrocyte cell function is critically
affected by the lack of oxygen supply (hypoxia) to the brain
which is usually associated with TBI (Conrad et al., 1999).
It is vital for the brain to adapt and/or tolerate the changes
in oxygen level with appropriate cellular mechanisms. One of
the most extensively studied mechanisms of hypoxia under
ischaemic conditions, is the role of hypoxia-inducible factor-1
(HIF-1) (Ziello et al., 2007; Loor and Schumacker, 2008). HIF-
1 is a transcription factor, which has a pivotal protective role
in enhancing the cellular adaptation to hypoxic stresses (Badawi
et al., 2012). ActivatingHIF-1 results in transcriptional regulation
of various genes associated with the adaption mechanism
and promoting cellular survival in hypoxia. However, the
specific intracellular mechanisms involved in such processes and
following hypothermic intervention are not fully understood.
As astrocytes are closely associated with neuronal function
and regulation and remain mitotic, it would be therapeutically
beneficial to understand their cellular pathophysiology following
TBI and edema formation (Dienel and Hertz, 2005; Nedergaard
and Dirnagl, 2005; Previch et al., 2016).
Therapeutic hypothermia has been widely studied for its
neuroprotective effect, mainly against apoptosis and necrosis
in neurons (Yenari and Han, 2012). More recent studies
have assessed its effect on hypoxic and anoxic brain injuries
(Shankaran et al., 2005). Additionally, hypothermia is considered
to play an essential role in slowing or stopping some critical
metabolic processes without resulting in death, referred to as
“suspended animation” (Nozari et al., 2004). An incomplete
understanding of the role of astrocytes and the complex
interplay among signaling pathways (together with poorly
defined treatment windows) are thought to be factors in
the clinical failure of hypothermia (Andrews et al., 2015).
Understanding the effects of therapeutic hypothermia in
astrocytes may shed light on neuroprotective mechanisms and
identify new drug targets and/or improved combined therapeutic
approaches.
To gain insight into the complex mechanisms that mediate the
effect of hypothermic intervention following ischemia/hypoxia,
a comprehensive transcriptomic profiling of gene expression,
using microarray analysis, was carried out and the resultant
outcome further investigated using validation techniques at both
the mRNA and protein level.
In this study, the transcriptome profile analysis of gene
expression in primary human cortical astrocytes was analyzed
to investigate the global transcriptional response in an in
vitro cellular model of cytotoxic edema on primary human
cortical astrocytes, with and without mild hypothermic
intervention. A primary goal of the study was to identify
the pathways and related functions that might be mediated
by hypothermic intervention. Hence, the differential gene
expression of human primary cortical astrocytes grown under
hypoxic conditions (5% O2) for 6 h and the effect of 32
◦C
hypothermic intervention after initial incubation for 2 h of
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hypoxia (hypoxia+hypothermia; for the total of 6 h) was
investigated. These conditions and time points were selected
to mimic hypoxia following brain injury and a typical clinical
intervention following hypoxia after traumatic injury (Ma
et al., 2012; Andresen et al., 2015). This is aimed at reducing
early cytotoxic edema formation and the likelihood of surgical
intervention.
Bioinformatic analysis has been used to identify pathways that
could be involved in the effects of hypothermia. PCR profiling
and ELISA were used to validate the microarray findings at the
transcriptional and translational levels, respectively. Proteome
profiling Array (PPA) has been used to investigate the effect of
hypothermic intervention on human apoptosis-related proteins
in hypoxic astrocytes.
The genes and proteins affected by hypothermic intervention
following hypoxia could be targeted as potential candidates for
functional validation and have potential translational value for
reducing edema formation following TBI and/or stroke.
MATERIALS AND METHODS
Cell Culture
Primary human cortical astrocytes (Sciencell, Cat. No. 1800) were
plated on 75 cm2 culture flasks (Thermo Scientific Nunc Cell
Culture Treated EasyFlasks) and cultured routinely in Astrocyte
Medium (Sciencell; 1801) containing 1% fetal bovine serum
(FBS, Sciencell Cat. No. 0010), 5ml astrocyte growth supplement
(AGS, Sciencell Cat. No. 1852) and 5ml penicillin/streptomycin
solution (P/S 1%, Sciencell Cat. No. 0503). The cells were then
incubated either in humidified 5% (v/v) CO2 in air at 37
◦C
for the normoxia work or in a controlled hypoxic atmosphere
using a Coylab Hypoxia Chamber Glove Box, with a humidified
airtight apparatus with inflow and outflow valves (into which
a mixture of 95% N2 and 5% CO2 was flushed) for the
hypoxia-related experiments. The effect of hypoxic intervention
using the indicated chamber were validated by investigating the
differential expression of Hypoxia-inducible factor 1-alpha (HIF-
1α). The α subunit of HIF is considered to be the O2-sensitive
subunit, constitutively destroyed during normoxia. However
hypoxia is known to stabilize the expression of HIF-1α subunit,
resulting in more HIF-1α activation and the subsequent HIF-1α
mediated hypoxic response (Tanaka et al., 2009). The chamber
was sealed to maintain the gas composition and kept at 37◦C
for experiments under normothermic conditions or 32◦C for
hypothermia-related work. Astrocytes were grown either under
hypoxic conditions (5% O2) for 6 h (hypoxia) or under 32
◦C
hypothermic intervention after initial incubation for 2 h of
hypoxia (hypoxia+ hypothermia; for the total of 6 h). Astrocytes
used for the experiments were at low (5 or below) passage number
and the expression of AQP4 and GFAP (archetypal biomarkers
for astrocytes) was regularly checked to ensure that they were
not de-differentiated. Cellular proliferation and viability was
determined by measuring the amount of ATP generated by
viable cells using the CellTiter-Glo R© luminescent cell viability
assay (Promega, Cat. No. G7570) as per the manufacturer’s
instructions. The results indicated that cell viability levels were
92, 86.4, and 90.3% for normoxic control, 6 h hypoxia and 6 h
hypoxia+hypothermia; respectively.
RNA Extraction, cDNA Synthesis and
Purification, and Quantitative Real-Time
Polymerase Chain Reaction
Total RNA was isolated from primary human cortical astrocytes
with RNeasy plus mini kit (Qiagen; Cat. No. 74134). cDNAs
were generated from 1µg total RNA (or 8µl from total RNA
samples with less than 125 ng RNA) by SUPERSCRIPT III RNase
H with oligo (dT)18 (Applied Biosystems; Cat. No. 18080400).
The cDNAs were purified using the QIAquick PCR purification
kit (Qiagen; Cat No. 28104) and multi-target RT-qPCR was then
performed on a StepOnePlusTM Real-Time PCR System (Applied
Biosystems) using purified cDNA samples to investigate gene
expression levels of the investigated genes. The following Taqman
assay IDs were used: HIF-1α (Hs00153153_m1) in addition
to PPIA (Hs99999904_m1) and CDKN1B (Hs00153277_m1)
which were used as housekeeping genes (Applied Biosystems)
(Ayakannu et al., 2015; Salman et al., 2017; Tan et al., 2017).
2µl containing 10 ng cDNA were used in the preparation of the
10µl reactions using the TaqMan Universal PCR Master Mix
(Applied Biosystems; Cat. No. 4324018). Samples were run for
50 cycles and results were analyzed using the 2−11Ct method
(Schmittgen and Livak, 2008) and presented as relative gene
expression normalized to the average cycle threshold for the two
housekeeping genes.
RNA Preparation and Quality Control
Total cellular RNA was isolated as previously described in
2.2. To reduce interference in qPCR analysis caused by poor
RNA quality, extracted RNA was assessed for its concentration,
purity and integrity using a Nanodrop 1000 Spectrophotometer
(Thermo Scientific) and an Agilent 2100 Bioanalyzer instrument
(Agilent, Wokingham, UK). The RNA concentration was within
the range 10–200 ng/µL; 260/280 nm absorbance ratio was≥ 1.9;
260/230 nm ratio was ≥ 1.9; 28S/18S ribosomal ratio was ≥ 2;
and RNA Integrity Number (RIN) was≥ 9. These recommended
conditions (Zhang et al., 2004) were met in order to consider any
RNA sample for subsequent steps.
Microarray
Microarray analysis was carried out using the Agilent one
color methodology for low RNA input using G3 human gene
expression 8 × 60K v3 microarray (G4858A-072262), according
to themanufacturer’s instructions (Agilent). Briefly poly A spike–
ins were prepared and added to 200 ng total RNA in a 3.5µl
reaction mix; quantified using NanoDrop spectrophotometer.
T7 primer mix and first strand buffer were added and cDNA
prepared. A transcription mix was then used to prepare cRNA
with Cy3 labeled cytidine residues. Following purification and
quantification of the reaction success, an appropriate quantity
of these molecules was fragmented before being incorporated
into a hybridization cocktail and applied to the microarray
slide. The Agilent 8 × 60 design was used and samples
distributed across the gasket slide upon which the array slide
was placed and the hybridization assembly prepared. Following
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overnight incubation at 65◦C with rotation at 10 rpm, the
assembly was disassembled in a low stringency wash buffer
(Agilent) and following further stringency washes the slide(s)
were scanned in an Agilent C scanner. The resultant image
files were further examined using Agilent Feature extraction
software to produce the.txt files, which were interrogated for
quality control and differential expression analysis using Agilent
GeneSpring software.
Microarray Analysis
Gene Spring (v13.1.1 from Agilent) was used to determine
a difference in transcript expression which was considered
significant if a fold change (FC) ≥ 1.5 and a corrected p-value
< 0.05 was determined on (n = 2) independent extractions
from the cells on two individual microarray analyses. The
full list of the up- and down- regulated genes following the
comparison are provided. The list of up- and down-regulated
genes was submitted to the bioinformatics and functional
annotation tool provided by DAVID, version 6.7 (Huang da
et al., 2009a,b). The KEGG pathway enrichment analysis then
identified potential pathways that were associated with the
mechanismsmediated by the hypothermic and/or hypoxic effects
of astrocytic pathophysiology (http://david.abcc.ncifcrf.gov/). To
minimize false positives among significantly-enriched functions,
a false discovery rate (FDR) ≤0.05 (−log P-value = 1.33) was
used to determine the probability that each biological function
assigned to that data set was due to chance alone. KEGGpathways
with enrichment score (ES) > 1.3 were considered significantly
enriched.
Gene ontology (GO); the up-regulated and down-regulated
genes identified from GeneSpring software analysis were
submitted separately to DAVID, version 6.7 (Huang da et al.,
2009a,b) and subsequent GO terms were identified using the
same statistical parameters. GO terms and categorization of
the up- and down-regulated genes according to their known
molecular function following each of the indicated comparisons
have been performed and for simplicity, various GO terms in
broader Gene Ontology Biological Processes (GO_BP) categories
were grouped as shown in Supplementary Table 1).
Pathway-Specific Expression Arrays (RT2
PCR Profiler Array)
cDNA was synthesized using the RT2 first strand kit
(SABiosciences, Qiagen) from 500 ng total RNA and qPCR
reactions were performed using RT2 SYBR R© Green qPCR
Mastermix (Qiagen; Cat. no. 330529); both were performed
according to the manufacturer’s instructions. An RT2 Profiler
PCR array specific for Wnt signaling pathway plus (Qiagen, Cat.
no. PAHS-043Y) and one specific for MAPK signaling pathway
(Qiagen, Cat. no. PAHS-061Z) components were used to assess
the transcript levels of 168 different genes using StepOnePlusTM
Real-Time PCR System (Applied Biosystems). A full list of genes
used in this study along with unigene ID, RefSeq numbers, gene
symbol and description, are listed in Supplementary Tables 2, 3,
respectively.
Raw CT values were analyzed using the SAB PCR Array
Data Analysis Web Portal online analysis software (http://
pcrdataanalysis.sabiosciences.com/pcr/arrayanalysis.php).
Samples were assigned to controls and test groups. CT values
were normalized based on an automatic selection from
housekeeping genes (HKGs) panel of reference genes. The data
analysis web portal autogenerates fold change/regulation using
delta delta CT method, in which delta CT is calculated between
gene of interest (GOI) and an average of HKGs, followed by
delta-delta CT calculations (delta CT [hypoxia+hypothermia
Group)-delta CT (hypoxia Group)]. Fold Change (FC) is then
calculated using 2∧ (-delta delta CT) formula by dividing
the normalized gene expression [2∧ (-Delta CT)] in the
hypoxia+hypothermia samples by the normalized gene
expression [2∧ (-Delta CT)] in the hypoxia only samples (which
is considered as a control for the analysis). Fold-change values
greater than one indicate a positive or an up-regulation, and
the fold regulation is equal to the fold-change. Fold change
values less than one indicate a negative or down-regulation, and
the fold-regulation is the negative inverse of the fold-change.
All array internal quality controls were similarly calculated to
indicate an absence of genomic contamination, optimal reverse
transcription efficiency, and high sensitivity (SABiosciences
online analysis software).
Cell Based ELISA Measuring MAPK Protein
Expression and Activity Levels
Primary human cortical astrocytes were pre-treated with
hypoxia or hypoxia+hypothermia as indicated in 2.1. Total and
phosphorylated protein levels of p38 and JNK MAPK were
determined using cell based ELISA kit (RayBio R© Cell Based, Cat
No. CBEL-ERK-SK, Ray Biotech Inc., Norcross, GA, USA) as per
manufacturer’s instructions.
Proteome Profiling
Proteome ProfilerTM Human Apoptosis Array Kit (R&D Systems;
Catalog # ARY009) was used to analyse the expression profiles
of apoptosis-related proteins. Protein was extracted using
CelLyticTM as described above). The total protein concentration
was determined using PierceTM BCA Protein Assay Kit. Each
proteome profiler membrane was then incubated with 250µg
of protein lysate per each array and diluted to the final volume
of 1.25mL of Array Buffer 1, according to the manufacturer’s
instructions. The HRP-conjugated streptavidin provided in the
kit was replaced with IRDye R© 800CW Streptavidin (LI-COR,
926-32230) and it was diluted at 1:2000 using the array Buffer 2/3
(R&D Systems, ARY009). All the following steps were performed
according to the manufacturer’s instructions. The arrays were
scanned with LI-COR Odyssey R© Infrared Imaging System and
quantified with Image StudioTM software (LI-COR) to determine
the relative amount of the specific proteins. A full list of the
investigated proteins is provided in Supplementary Table 4.
Statistical Analysis
Data are presented as a fold-change normalized to the
experimental control. Microarray analysis, RT-qPCR expression,
ELISA and Proteome Profiling data were found to be
nonparametric in distribution using the Shapiro-Wilk test,
so a Kruskal–Wallis analysis with Conover– Inman post hoc
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test was used to identify significant differences (P ≤ 0.05) using
StatsDirect 3 software.
RESULTS
Effect of Hypoxia on Primary Human
Cortical Astrocytes
To validate the impact of hypoxia on primary human cortical
astrocytes, the expression of HIF-1α was investigated at the
mRNA and protein level using RT-qPCR and as part of the
proteome profiling array, respectively. This was measured with
and without hypothermic intervention and the results presented
as fold change compared with the normoxic control. The results
in Figure 1A show that hypoxia caused a significant upregulation
of HIF-1α mRNA (4.05-fold ± 0.05; p<0.0003) compared to
untreated control astrocytes. Hypothermic intervention caused
a significant reduction in the hypoxia-induced upregulation by
1.94-fold ± 0.11(p < 0.01) but the levels were still significantly
higher than the untreated control astrocytes (2.11-fold ± 0.11; p
< 0.01).
Hypoxia led to a significant upregulation in HIF-1α protein
expression (3.62-fold± 0.06; p< 0.0014) compared to untreated
control astrocytes (Figure 1B). Moreover, hypothermia reduced
the hypoxia-induced expression of HIF-1α protein by 0.74-fold
(±0.018; p < 0.0017) but the level was still significantly higher
than untreated control cells (2.88-fold ± 0.05; p < 0.0034).
These results confirm a measurable effect of hypoxia treatment
at both the mRNA and protein level in primary human astrocytes
(Figure 1B).
Gene Expression Profiles Using Microarray
Analysis
Transcriptional profiling of primary human cortical astrocytes
was measured using Agilent single color G3 technology,
under hypoxia or hypoxia+hypothermia. Comparison of
hypoxia treatment of astrocytes, with and without hypothermia
intervention, revealed 411 differentially regulated genes (209
down-regulated and 202 up-regulated) following GeneSpring
analysis (A full list of the up- and down-regulated genes is
provided in Supplementary Tables 5A,B).
KEGG Analysis of Functional Pathways
To obtain biological information for describing the molecular
mechanisms and regulatory networks involved in hypothermic
intervention of hypoxia in human astrocytes, the microarray data
were assessed using KEGG enrichment pathway analysis (key
results summarized along with p-value and fold enrichment in
Table 1).
A primary focus of this study was to analyse
hypoxia+hypothermia versus hypoxia alone. The subsequent
KEGG analysis indicated that these genes were mainly enriched
in three major pathways: Hedgehog, Wnt and p53 signaling
pathways; which were inhibited following the hypothermic
intervention.
The pathway most enriched from the hypoxia+hypothermia
group compared with hypoxia alone (Table 1) was the
Hedgehog signaling pathway. The microarray results also
suggest that the Hedgehog signaling pathway mediates its
essential effects via the downstream involvement of the
Wnt signaling pathway in the transcriptional regulation
process (Figure 2A). The Wnt signaling pathway alone was
the second highest enriched pathway (3.5 fold; p = 7.00E-
03) (Table 1; Figure 2B). Additionally, further GO term
analysis indicated that the Wnt receptor signaling pathway
is the highest enriched biological process for the identified
differentially expressed genes (Supplementary Table 1).
Therefore, the differential transcriptional regulation of the
Wnt pathway in human astrocytes was investigated under
hypoxia with or without the hypothermic intervention at
the transcript level and further validating it at the gene level
using pathway specific RT2 Profiler PCR Arrays. Treating
astrocytes with hypothermia did not have an effect on the
Hedgehog or Wnt signaling pathways; and the results show that
hypothermia may mediate its effects mainly via interfering
with cell adhesion and adherens junction compared to
untreated normoxic normothermic astrocytes (E.score 4.9;
p-value= 4.60E-02).
Validation of Hypothermic-Intervention
Effects on Wnt and p53 Pathways Using
Pathway Specific RT2 Profiler PCR Arrays
The expression of 168 genes known to be involved in the Wnt
signaling pathway were examined to investigate whether basal
differences in transcription play a role in mediating the effect of
hypothermia following hypoxia on astrocytes using RT2 Profiler
PCR Arrays for Wnt signaling pathway molecules. The results
indicate the significant differential expression of 42 genes on the
array. Among them, 32 genes were significantly down-regulated
whilst the expression of only 10 genes were significantly induced
(Table 2).
The RT-qPCR array platform has an embedded analytical
score feature that is used to indicate the activity status of the
investigated pathway. A positive score indicates activation of the
pathway, whilst a negative score indicates repression. The results
indicated that the activity score was −0.721 (p < 0.01) which
reveals a significant inhibition of the Wnt signaling pathway
following hypothermic intervention on astrocytes under hypoxia
compared to astrocytes being cultured under hypoxia only (data
not shown). This agrees with the findings from the microarray
analysis (See Supplementary Table 1).
Comparing Protein Expression of Total and
Phosphorylated p38 and JNK Proteins
Using ELISA on Human Primary Cortical
Astrocytes
Transcriptional changes do not always reflect translational
alterations due to many factors such as the efficiency of
translation and the stability of the generated protein (Cenik et al.,
2015). p38 and JNK are key Wnt signaling pathway proteins that
mediate responses to a variety of cell stresses including ischemia,
stress stimuli (such as cytokines), ultraviolet irradiation, heat
shock and osmotic shock (Mielke and Herdegen, 2000; Wallace
et al., 2012). p38 and JNK are also known to be altered in
response to hypoxia in both neurons (Liu et al., 2009) and
astrocytes (Roy Choudhury et al., 2014; Jeong et al., 2017).
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FIGURE 1 | HIF-1α mRNA and protein expression levels in cultured primary human astrocytes following hypoxia or hypoxia+hypothermia. Data shown include mean
fold change in expression (± S.E.M.) of cells treated with 5% oxygen for 6 h with no temperature change (Hypoxia) or with 32◦C hypothermic intervention after initial
incubation for 2 h of hypoxia for a total of 6 h (Hypoxia + Hypothermia) compared with untreated normoxic, normothermic astrocytes (Control). Each bar represents
the Mean ± S.E.M. for each of the conditions. Kruskall-Wallis with Conover-Inman post-hoc analysis tests were used to identify significant differences between
samples using StatDirect 3 software. *Represents statistical significance (p < 0.001). (A) Shows RT-qPCR data (N = 5) using Taqman probes and 2∧−11CT analysis
normalized to the two housekeeping genes, PPIA and CDKN1B. (B) Shows Proteome Profiling Array data (N = 3). FC, Fold change.
It was also shown in these studies that the activation status
of these proteins may be as relevant as translational changes.
This study therefore used these examples to interrogate the
microarray findings at the protein level. The transcriptional
results for these two genes showed a significant inhibition at
the mRNA level using both the microarray (0.02 ± 0.007; p <
0.05; 0.23 ± 0.003; p < 0.05) and RT-qPCR (Table 2). To assess
the translational profile and activity status of these stress kinases
following hypoxia with or without hypothermic intervention, the
total and phosphorylated p38 and JNK protein expression levels
were measured using the cell based sandwich ELISA described in
the methods.
There was no significant difference in the total p38 (MAPK14)
protein levels following hypoxia, compared to the untreated
control (p= 0.23). Hypothermic intervention caused a significant
decrease in the pan p38 levels following hypoxia by 21% (±0.09;
p = 0.03) but not in comparison to the untreated control
where there was no significant change (p = 0.2). Regarding JNK
(MAPK8); 6 h hypoxia causes a significant upregulation (3.01-
fold ± 0.02; p < 0.0003) in regard to the untreated control
but the hypothermic intervention reduced the hypoxia-induced
upregulation and restores the pan-JNK levels to a level where
there is no detected statistical difference to the untreated control
(p= 0.46) (Figure 3A).
However, 6 h hypoxia caused a significant 2.64 fold ± 0.17 (p
= 0.0003) increase in the phosphorylated p38 (p-p38) protein
levels compared to control (Figure 3B), indicating that p-p38
is rapidly activated in primary human astrocytes in response
to hypoxia. Hypothermic intervention after 2 h significantly
down-regulated the hypoxia-mediated increase in p-p38 levels
by 35% ± 0.04 (p = 0.04). Despite the reduction following
the hypothermic intervention; the levels were still significantly
TABLE 1 | Comparison of KEGG pathway analysis of hypoxia+hypothermia vs.
hypoxia ranked according to p-value and fold enrichment for differentially
expressed genes in astrocytes.
KEGG pathways p-value Fold enrichment
1. Hedgehog signaling pathway 1.40E-03 7.1
2. Wnt signaling pathway 7.00E-03 3.5
3. p53 signaling pathway 1.8E-2 4.9
higher compared to the untreated control (1.7 fold ± 0.01; p <
0.004). 6 h hypoxia causes a significant increase in p-JNK protein
levels (2.73-fold ± 0.11; p < 0.011) compared to untreated
control (Figure 3B). Moreover, hypothermic intervention causes
a further increase in p-JNK protein levels compared to untreated
control and astrocytes being cultured for 6 h under hypoxia
(5.32-fold ± 0.07; p < 0.0001 and 2.59-fold ± 0.08; p = 0.008);
respectively.
Validation of the Effect of Hypothermic
Intervention on Apoptosis and p53
Signaling Pathways in Hypoxic Astrocytes
Table 3 shows that hypothermic intervention causes significant
downregulation of 18 proteins, while only significantly
upregulating survivin at the protein level (P < 0.05).
Transcription levels were determined by reanalysing the
MA data for each of these 19 individual genes to determine the
transcript expression level. In addition, the translational and
transcriptional expression FC was calculated by dividing the
gene or protein expression level in hypoxia/hypothermia by its
corresponding hypoxia value. The transcriptional data show
that there was a significant downregulation of BCL2 Associated
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FIGURE 2 | The distribution of differentially expressed genes in astrocytes following hypoxia+ hypothermia vs. hypoxia: (A) Within the Hedgehog signaling pathway,
(B) Within the Wnt signaling pathway in primary human cortical astrocytes being cultured under hypoxic conditions (5% O2) for 6 h with or without hypothermic
intervention (32◦C after 2 h; maintaining hypoxia for 6 h) (adapted from KEGG website: www.genome.jp/kegg). The significant up- and down-regulated genes,
indicated with red + signs, were identified using DAVID/KEGG enrichment analysis of microarray data (n = 2).
X (Bax) (P = 0.023), Bcl-2-like protein 1 (Bcl-x) (P = 0.029),
claspin (p = 0.03), Fas-associated protein with death domain
(FADD) (P = 0.034), HIF-1α (P = 0.023), Heat shock proteins
[HSP; including HSP32 (P = 0.006), HSP27 (P = 0.042), HSP70
(P = 0.006)], Serine protease HTRA2 (HTRA2) (P = 0.039)
and Cyclin Dependent Kinase Inhibitor 1B (CDKN1B) (P =
0.04) transcript expression level. While there was no significantly
detected change at the transcript level of Cyclin Dependent
Kinase Inhibitor 1A (CDKN1A) (P = 0.162), Cleaved Caspase-3
(CASP3) (0.248), Baculoviral IAP repeat-containing protein 3
(cIAP-2) (P= 0.468), Clusterin (P= 0.163), Rad17 (not detected)
and SMAC/Diablo (P = 0.239). Conversely, the transcriptional
result showed that livin and survivin were the only transcripts
that show a significant upregulation at the transcriptional level
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TABLE 2 | Fold regulation comparison and p-value for genes within the human
Wnt signaling and related pathways in human astrocytes under hypoxia with or
without hypothermic intervention (a full list of all the investigated genes is provided
in Supplementary Tables 2,3).
Unigene ID Gene symbol Fold change p-value
Hs.213424 SFRP1 −6.3451 0.005
Hs.282410 CALM1 −6.2696 <0.001
Hs.121540 WNT10A −5.7345 <0.001
Hs.584775 LRP6 −4.0256 0.011
Hs.149504 WNT9A −4.0151 <0.001
Hs.94234 FZD1 −3.9556 0.002
Hs.138211 MAPK8 −3.9479 <0.001
Hs.292156 DKK3 −3.9375 <0.001
Hs.40735 FZD3 −3.9292 0.049
Hs.516646 CREB1 −3.8994 <0.001
Hs.463978 MAP2K6 −3.4831 0.044
Hs.712929 CTNNB1 −3.2242 <0.001
Hs.23348 SKP2 −3.1765 0.03
Hs.194698 CCNB2 −3.1619 0.025
Hs.523852 CCND1 −3.1179 0.03
Hs.643085 WNT5A −2.8536 0.027
Hs.445884 WNT3 −2.5029 0.002
Hs.654934 DAAM1 −2.4984 0.002
Hs.258575 WNT2B −2.4898 0.002
Hs.512714 WNT7B −2.4728 0.002
Hs.485233 MAPK14 −2.4269 0.037
Hs.644231 ETS2 −2.1205 <0.001
Hs.437460 p53 −2.08 <0.001
Hs.19192 CDK2 −2.0198 <0.001
Hs.408528 RB1 −2.0135 <0.001
Hs.234521 MAPKAPK3 −1.9963 <0.001
Hs.696684 JUN −1.9679 <0.001
Hs.248164 WNT1 −1.9091 <0.001
Hs.592510 ATF2 −1.8732 <0.001
Hs.57732 MAPK11 −1.8633 <0.001
Hs.306051 WNT5B −1.7533 0.005
Hs.145605 MAP3K2 1.8447 0.004
Hs.390428 MAP3K4 1.8914 <0.001
Hs.514012 MAP2K3 1.9496 <0.001
Hs.643566 MAPKAPK2 1.9993 <0.001
Hs.40499 DKK1 2.0323 <0.001
Hs.433332 LAMTOR3 2.0336 <0.001
Hs.202453 MYC 2.0639 <0.001
Hs.649965 MEF2C 2.1279 0.001
Hs.326035 EGR1 3.1509 0.025
Hs.627078 CXADR 3.2143 0.002
(P = 0.003 and 0.001; respectively). Survivin; but not livin,
showed a similar trend at the protein data.
It is notable to mention that proteome profiling array
investigated three different sites of Phosphorylated-p53 protein
at (S15), (S46), and (S392) and it was only the Phospho-p53 (S15)
that showed a significant downregulation at the protein level,
which could indicate the initial effect of hypothermia might be
mediated through affecting the phosphorylation (and hence the
activation) of different residues within the p53 protein.
DISCUSSION
Brain injuries such as TBI and stroke are usually associated
with a state of hypoxia that results in glial activation (Kou
and VandeVord, 2014). Glial cells, in particular astrocytes, play
a major role in maintaining CNS homeostasis and protection
from various stresses, by providing metabolic and structural
support (Bélanger and Magistretti, 2009). Hypoxia can disrupt
astrocyte homeostasis leading to cell swelling (Liang et al.,
2007). This cytotoxic edema is one of the main deleterious
effects of TBI, in some cases causing brain damage and death.
Hypothermia has been shown to have a neuroprotective effect
against glial activation associated with brain injury and cerebral
hypoxia (Karnatovskaia et al., 2014). The therapeutic use of
mild hypothermia is well established in animal models but
it has a limited application in humans, due to the poorly
definedmechanism of action (Yenari and Han, 2012). Identifying
the mechanistic consequences of therapeutic hypothermia in
primary human astrocyte cultures will help to elucidate the
complex response in the central nervous system, as it provides
a more physiologically relevant model compared to the most
commonly used rodent cellular and/or animal models. This will
also be important in terms of validating new drug targets due to
the fact that oxygen differentially regulates gene expression in a
cell-specific and species-specific manner (Mense et al., 2006).
HIF-1α
It is well known that hypoxia induces many signaling pathways in
astrocytes such as HIF-1α, NF-κB, p53, cAMP, CREB and c-jun
(Rosenberger et al., 2001), all of which could affect astrocyte
survival (Vangeison and Rempe, 2009). The results in this
study show that hypothermia significantly reduced the mRNA
expression of HIF-1α, CREB1, JUN and TP53, which was also
confirmed at the protein levels for HIF-1α.
Ischemia is one of the main causes of cerebral hypoxia. HIF-
1α is a protein that plays a major role in oxygen homeostasis
in body tissues including the brain and is considered an oxygen
sensor and it is well established that oxygen tension plays a major
role in its activation (Semenza, 1999; Tanaka et al., 2009; Ding
et al., 2010). HIF-1α abundance is very low under normoxic
conditions, as it rapidly undergoes degradation via ubiquitination
and proteasome degradation (Jaakkola et al., 2001). It has been
shown that this protein is up-regulated during cerebral hypoxia
due to an inhibition of the degradative process (Mu et al., 2003).
This upregulation is associated with harmful outcomes such as
blood–brain barrier (BBB) disruption or cell death mediated
by different target genes (Kaur et al., 2006). It is well-known
that therapeutic hypothermia significantly decreases HIF-1α neo-
synthesis following hypoxia, inhibiting the gene expression for
adaptation to hypoxia in both in vivo and in vitro models
(Tanaka et al., 2009). The results (Figure 1) confirmed these
findings by showing that hypoxia significantly upregulated HIF-
1α at both gene and protein levels. This also serves as a useful
control, validating our cellular model of in vitro cytotoxic edema.
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FIGURE 3 | p38 and JNK (A) total and (B) phosphorylated protein levels in cultured human astrocytes using sandwich ELISA. Data are mean fold changes in
expression (± S.E.M.) of cells incubated at 5% O2 for 6 h (“hypoxia”) and hypothermic intervention after 2 h (32
◦C; maintaining hypoxia for 6 h) (“hypoxia+hypothermia”)
normalized to normoxic normothermic (“Control”) astrocytes. Each bar represents the mean ± S.E.M. for each of the conditions (n = 4). Kruskal-Wallis with
Conover-Inman post-hoc analysis tests were used to identify significant differences between samples. *Represents statistical significance (p < 0.05).
The hypothermia induced significant down-regulation of HIF-1α
mRNA and protein could be part of the mechanism by which
hypothermia mediates its neuroprotective effect on astrocytes.
Microarray Analysis
The microarray analysis identified 411 differentially expressed
genes following hypothermic treatment of human astrocytes
cultured under hypoxia. The subsequent KEGG analysis
indicated that these genes were mainly enriched in three
major pathways: Hedgehog, Wnt and p53 signaling pathways;
which were inhibited following hypothermic intervention. The
pathway most affected from the hypoxia+hypothermia group
compared with hypoxia alone was the Hedgehog signaling
pathway. The evolutionarily conserved Hedgehog (Hh) complex
pathway is fundamental for embryonic development and exhibits
essential roles in cellular survival, and adult tissue maintenance,
regeneration and renewal (Mimeault and Batra, 2010). It
mediates its effect via the secreted Hh proteins that act in
a concentration- and time-dependent manner to initiate a
series of cellular responses through transcriptional regulation
(Mimeault and Batra, 2010). Despite being the pathway with the
highest enrichment score, the microarray results also suggested
that the Hedgehog signaling pathway mediates its essential
effects via the downstream involvement of the Wnt signaling
pathway in the transcriptional regulation process (Figure 1A,
Table 2).
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TABLE 3 | Fold regulation comparison for significant proteins within human p53
and apoptosis signaling and related pathways and their corresponding gene
expression from the microarray data analysis.
Target name Gene fold change ± S.E.M. Protein fold change
± S.E.M.
Bax 0.15* ± 0.03 0.43* ± 0.07
Bcl-x 0.24* ± 0.21 0.36* ± 0.17
Cleaved Caspase-3 – 0.73* ± 0.12
cIAP-2 NS 0.55* ± 0.07
Claspin 0.32* ± 0.27 0.84* ± 0.08
Clusterin NS 0.56* ± 0.19
FADD 0.11* ± 0.05 0.82* ± 0.05
HIF-1α 0.06* ± 0.01 0.79* ± 0.02
HO-1/HMOX1/HSP32 0.38* ± 0.03 0.54* ± 0.05
HSP27 0.38* ± 0.02 0.78* ± 0.13
HSP70 0.4* ± 0.01 0.71* ± 0.1
HTRA2/Omi 0.35* ± 0.06 0.49* ± 0.19
Livin 2.17* ± 0.02 0.47* ± 0.09
p21/CIP1/CDKN1A NS 0.45* ± 0.21
p27/Kip1 0.35* ± 0.03 0.59* ± 0.27
Phospho-p53 (S15) 0.43* ± 0.01 0.67* ± 0.14
Phospho-Rad17 (S635) – 0.65* ± 0.02
SMAC/Diablo NS 0.60* ± 0.25
Survivin 5.77* ± 0.49 1.41* ± 0.12
35 human apoptosis-related proteins closely associated with the Wnt signaling pathway
were investigated using a Proteome Profiling array. Data shown include mean fold change
(± S.E.M.) of significantly altered proteins in astrocyte cell lysates treated with 5% O2 for
6 h with no temperature change (hypoxia) or with a 32◦C hypothermic intervention after
initial incubation for 2 h of hypoxia (hypoxia+hypothermia; for a total of 6 h). Fold change
(FC) was obtained by dividing the mean of the expression level in hypoxia+hypothermia by
the mean of its corresponding hypoxia expression level. The data represent a comparative
analysis for selected significantly expressed proteins (normalized to array control) and
their corresponding genes (normalized to array signal) and in hypoxia+hypothermia and
hypoxia. The results are presented as mean ± S.E.M. for microarray analysis (n = 2) and
proteome profiler analysis (n = 3). Kruskal-Wallis with Conover-Inman post hoc analysis
was used to identify significant differences between samples ( *P < 0.05, NS = not
significant, – not detected in the microarray analysis).
The Wnt signaling pathway on its own (Figure 1B, Table 2)
had the second highest enrichment score. Interestingly, the
idea of Wnt signaling involvement is further supported by the
results from the GO term analysis, which indicated that the Wnt
receptor signaling pathway and its calcium modulating pathway
were the highest enriched biological processes for the identified
genes (Supplementary Table 1). Moreover, the remaining
upregulated differentially expressed genes identified within the
Wnt signaling were mainly associated with direct antagonism
of the canonical Wnt signaling mainly including Dickkopf-
related protein 1 (DKK1). DKK1 antagonizes canonical Wnt
signaling by inhibiting the low-density lipoprotein-related
receptor (LRP5/6) interaction withWnt and by forming a ternary
complex with the transmembrane protein kringle domain-
containing transmembrane protein 1 (KREMEN1) that promotes
internalization of low-density lipoprotein receptor (LRP5/6)
(Mao et al., 2002). DKK1 was also reported to antagonize the
Wnt/β-catenin pathway through a reduction of β-catenin and an
upregulation in octamer-binding transcription factor 4 (OCT4)
expression (Ou et al., 2016).
Wnt Signaling
Analysis of the microarray data identified inhibition of the
Wnt signaling pathway following hypothermic intervention on
astrocytes under hypoxic conditions compared with hypoxia
alone. Conversely analysis of the microarray data comparing
astrocytes cultured under hypoxia with the untreated normoxic
control cells suggested that hypoxia caused an activation of Wnt
signaling pathway in agreement with earlier findings (Mazumdar
et al., 2010).
The RT-qPCR data confirmed our microarray findings
regarding inhibitory effects of hypothermic intervention on
Wnt signaling for hypoxic astrocytes. The hypothermia-mediated
inhibition of Wnt signaling in the RT-qPCR data may be
mediated through several possible mechanisms such as the direct
inhibition of a number of Wnt signaling elements including
Wnt1, Wnt2B, Wnt3, Wnt5A, Wnt7B, Wnt9A and Wnt10A or
through the inhibition of key downstream components of the
canonical Wnt signaling pathway such as β-catenin (CTNNB1)
as shown in the RT-qPCR data. Wnt inhibition could be also
mediated through the direct activation of direct Wnt antagonists
such as DKK1 (Niida et al., 2004) which was shown by RT-qPCR
to be significantly upregulated.
Wnt inhibition could also be mediated through the inhibition
of other related genes or closely linked signaling pathways.
The RT-qPCR data show that there is an inhibition of secreted
frizzled-related protein 1 (SFRP1). In general, SFRPs function
as soluble Wnt signaling modulators, and they are known to
be activated by hypoxia (Fukuhara et al., 2002). The binding
of SFRPs and Frizzled (FZD) receptors; a family of G protein
coupled receptors within the Wnt pathway; is thought to
form a complex that inhibits Wnt signaling (Chim et al.,
2007).
There was a marked inhibition of FZD1 and FZD3 receptors.
The majority of FZD receptors were linked to the β-catenin
canonical signaling pathway that promotes the activation of Wnt
genes and Disheveled proteins and the decrease of glycogen
synthase kinase 3(GSK3) kinase activity. They are also linked to
signaling pathways involving PKC and calcium influxes where
PKC is suggested to be needed for Wnt mediated GSK3 kinase
inhibition (Cook et al., 1996). The inhibition of FZD1 and FZD3
in the experiments reported here could be due to Wnt3, Wnt1
and Wnt2b for FZD1 or Wnt5a for FZD3 (Blagodatski et al.,
2014). Moreover, there was also a significant downregulation of
Disheveled-associated activator of morphogenesis 1 (DAAM1),
which plays a role in cell adhesion, cytokinesis and polarity
through its binding to Disheveled (Dvl) and Rho, where it could
play a role as a scaffolding protein that enhances Rho-GTP
formation (Habas et al., 2001). It also has an important role
in mediating the cellular polarity via directing the nucleation
and elongation of new actin filaments, which could result in
changes in astrocyte morphology (Ang et al., 2010; Ju et al.,
2010).
MAPK Signaling
MAPK pathways are important intracellular signal transduction
pathways involved in the protective response of cells to hypoxia
and they play a key role in signaling cascades and within the Wnt
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pathway (Bikkavilli and Malbon, 2009). Intracellular signaling
cascades are of interest after TBI because they are involved
in the regulation of cellular repair, plasticity and homeostatic
functions, which are markedly altered in response to TBI (Huang
et al., 2009c). It is now well documented that the MAPK
pathway represents a highly conserved upstream mechanism for
transducing stress signals in eukaryotic cells (Guyton et al., 1996;
Garrington and Johnson, 1999; Mielke and Herdegen, 2000).
The results from this study indicated that hypothermia
significantly inhibits the MAPK pathways for p38 and
JNK at both total protein and mRNA level, compared to
hypoxia-induced elevated levels. Hypoxia caused a significant
upregulation of the phosphorylated forms of p38 and JNK,
which are known to be activated soon after TBI in astrocytes
in vitro (Rosenberger et al., 2001; Wallace et al., 2012), and
temperature markedly altered these responses (Huang et al.,
2009c). Additionally, the results reported in this study show that
hypothermia induced further activation of the phosphorylated
forms of JNK, but not p38; these results for the increased
phosphorylation of JNK but not p38 are in agreement with
earlier reports that showed increased phosphorylation of JNK in
cortical and hippocampal samples in a rat fluid-percussionmodel
of TBI (Otani et al., 2002) and that hypothermia protects against
TBI by the early inhibition of JNK activation and subsequent
prevention of apoptosis in astrocytes (Ma et al., 2012).
Hypoxia and oxidative stress are typical physiological factors
that affect the MAPK signaling pathway and, in particular,
p38 (Conrad et al., 1999). The results here show a significant
inhibitory effect of hypothermia on p38 activation, mRNA
and total protein levels. This inhibition of the phosphorylated
p38 protein occurred despite the significant upregulation at
the mRNA level of known p38 activators such as MAPK3K4
(Takekawa et al., 1997), MAP2K3 (Raingeaud et al., 1996), and
MAPKAPK2 (Rousseau et al., 2002; Tollenaere et al., 2015).
Hypothermia mediated suppression of p38 activation suggests
that hypothermia could mediate part of its neuroprotective
effect via inhibiting inflammation (Diestel et al., 2009), cellular
death and apoptosis (Yang et al., 2010). Thus, there is some
indication that p38 inhibition could be a promising therapeutic
target for hypothermia-mediated anti-inflammatory effects and
for reducing brain injury and neurological pathology during the
acute phase of cytotoxic edema (Barone et al., 2001).
The JNK signaling cascade plays a central role in the CNS
including the regulation of apoptosis and regeneration of both
neuronal and glial cells (Herdegen et al., 1997). The activation
of JNK signaling can be induced by various cytotoxic stresses
e.g., inflammatory cytokines, ischemia/hypoxia, and thermal
shock (Huang et al., 2009c; Wallace et al., 2012). The results
suggest that hypothermia modulates the early transient phase of
hypoxia-mediated JNK stimulation that could regulate astrocytic
survival which is in agreement with previous findings from
the work of Ventura et al. (2006). The increase in activation
of phosphorylated JNK protein agrees with the RT-qPCR
results in this study that showed a significant upregulation
of MAP3K2 (Cheng et al., 2000) and MAP3K4 (Takekawa
et al., 1997), which are also known to be involved in JNK
activation.
Hypothermia is known to cause a significant stimulation
of JNK signaling intermediates (Lotocki et al., 2006). Linking
these data with the observation of inhibited c-jun at the
mRNA level from RT-qPCR suggests that hypothermia could
result in the disruption of the JNK–c-Jun signaling pathway
(Tournier et al., 2000; Noguchi et al., 2001; Kögel et al., 2005;
Lotocki et al., 2006). Collectively, the present study suggests that
hypothermia could mediate part of its neuroprotective effects
via the downregulation of JNK levels following the oxidative-
mediated insult on astrocytes.
Apoptosis
Cellular death following ischemia and cerebral edema happens
either by necrosis, which represents the premature death of the
damaged cells or as part of the cascade of programmed cell death,
or apoptosis (Frink et al., 2012). Apoptotic cell death is the most
important mechanism contributing to cell loss following head
injury and therefore the modulation of apoptotic cell death after
hypoxia through hypothermia has been investigated (Ma et al.,
2012).
Previous reports have suggested a role for hypothermia
in reducing ischemia-mediated apoptosis and improving cell
survival in animal models via decreasing p53 expression (Zhang
et al., 2010). Additionally, hypothermia causes a reversible, p53-
mediated cell cycle arrest in cultured fibroblasts (Matijasevic
et al., 1998). This study showed a significant inhibition of p53
gene expression, which was confirmed by the protein data. This
may suggest that a mechanism of action of hypothermia could be
suppression of the early events of intrinsic apoptosis. These data
could be linked to the significant inhibition of genes belonging
to the highly-conserved cyclin family. The results demonstrated
that hypothermia causes a significant downregulation of CCNB2,
CCND1 and RB1 genes in addition to significant inhibition of
Cyclin-dependent kinase 2 (CDK2). Each of these have been
shown to play important roles in the regulation of the cell
cycle and their inhibition may play a role in altered modulation
of the cell cycle, leading to apoptotic cell death (Senchenko
et al., 2015; Otto and Sicinski, 2017). Further links with the
role of hypothermia in slowing down the events involved in
the cell cycle and regulation of the apoptosis response, is
indicated by inhibition of S-phase-associated kinase protein-2
(Skp2) which plays a major role in mediating the ubiquitination
and subsequent proteasome degradation of p27(kip1), which is
known to be involved in regulation of the G1/S transition during
the cell cycle; and it also plays a role in neurogenesis, signal
transduction and transcription (Podmirseg et al., 2016). It has
been reported that Skp2 is up-regulated after TBI and this is
linked to the inhibition of p27(kip1) expression and astrocyte
proliferation (Liu et al., 2010). Thus, the hypothermic effect
might be linked to astrocyte fate and survival following reduced
blood and oxygen in TBI and cerebral edema.
It is established that hypothermia has both positive and
negative effects upon many transcriptional regulation and
adaptive responses. One of the possible negative effects suggested
by the data here is the inhibition of some protective factors
that attenuate the oxidative stress-mediated DNA damage such
as the inhibitory effect on cyclic AMP-dependent transcription
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factor (ATF-2), a transcriptional activator and regulator for a
large number of genes such as those involved in anti-apoptosis
and DNA-damage and cell proliferation responses through its
binding to CREB (cAMP response element). ATF-2 has also been
shown to be inhibited in response to hypothermic intervention
(Walluscheck et al., 2013). The downstream signaling of ATF is
mediated through its binding to c-Jun or CREB (Harrison et al.,
2004) and that it has been shown that its activation is increased
via phosphorylation by p38 MAPK and JNK protein kinases
(Pearson et al., 2001; Gadea et al., 2008).
At the protein level, the array results indicated that
hypothermia significantly downregulated 18 proteins that have
mixed pro- and anti-apoptotic effect (Table 3). The evidence
that hypothermia caused a decrease in apoptosis agrees with
various previous studies (Lee et al., 2012; Yenari and Han, 2012).
Although hypothermia seems to have a global inhibitory effect,
there was an interesting upregulation of only one protein during
this acute phase, survivin. Survivin is an anti-apoptotic protein
that depresses apoptosis via decreasing caspase 3 expression
(Li et al., 2011). Survivin has been associated with the extent
of vascularization within the infarct region (Conway et al.,
2003). This increase in survivin expression could be part of an
endogenous response mediated by hypothermia on astrocytes
following hypoxia. These results are in agreement with the
findings from Mormile et al. (2012) and suggests that part of
the therapeutic benefit of hypothermia following hypoxia could
be mediated by modulating survivin expression. Further studies
are needed to understand the basic mechanisms associated
with survivin regulation and function in astrocyte treated with
hypothermia.
These results indicate that hypothermia could interfere with
the main early events of apoptosis through its inhibitory effect on
p53, HIF-1α and CREB and by enhancing the astrocytic survival
in response to oxidative-stress mediated damage via interfering
with the cell cycle regulatory processes and/or other essential
elements, including survivin. Despite its beneficial effects during
the acute phase of cytotoxic edema, hypothermia might also
lead to a general slowing down effect that may include some
essential cell survival events or enzymatic cascades (Boutilier,
2001; Goossens and Hachimi-Idrissi, 2014).
CONCLUSION
This study provides the first detailed longitudinal investigation at
the gene and protein expression levels of the molecular effects
of therapeutic hypothermic intervention following hypoxia on
primary cortical human astrocytes.
This study, for the first time, reports the involvement of Wnt
pathway inhibition as the most significantly affected signaling
cascade in the mechanism of hypothermia mediated response
following hypoxia- and oxidative stress- activated insult on
human astrocytes. Additionally, the results indicate that part
of the protective effect of hypothermic intervention following
hypoxia could be mediated through the inhibition of p38 and
JNK signaling.
Global inhibition of Wnt signaling could be problematic due
to its significant role in regulating essential processes involved in
the functional regulation of stem and immune cells along with
its effect on post-mitotic glial and neuronal cells (Chenn, 2008;
Munji et al., 2011); this could be avoided through dissecting this
generalized effect via specific targeting of signaling molecules.
Moreover, our results confirm the well-known effects
of hypothermic intervention on attenuating the hypoxia
activated HIF-1α- and p53-mediated apoptotic response. This
hypothermic intervention will have a beneficial effect on the
pro-inflammatory- and oxidative-stress-mediated elements but
it could contribute to some negative outcomes through slowing
down many essential molecules that are involved in the brain
repair processes.
These results highlight the existence of different options
for future therapies targeting cerebral diseases where injury-
and oxidative-stress mediated inflammation drives secondary
neurodegeneration, such as stroke and/or TBI.
The effects of hypothermia on astrocytes are complex
and there is no single factor that could explain its
neuroprotective effect, although it is possible that several
of these effects may share a common upstream activator.
Understanding the intracellular signaling networks underlying
the beneficial effects of hypothermia is essential for
discovery and validation of new potential therapeutic
targets identified in this study using a global transcriptomic
approach.
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